Loading data
ANVSNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | 0 USD |
| Research and development expense | 25.22 m USD | 20 m USD | 38.79 m USD | 16.52 m USD | 8.48 m USD |
| Operating profit | -29.7 m USD | -26.69 m USD | -45.04 m USD | -25.51 m USD | -14.54 m USD |
| Profit before tax | — | — | -56.2 m USD | -25.33 m USD | -14.49 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -28.85 m USD | -24.59 m USD | -56.2 m USD | -25.33 m USD | -14.49 m USD |
| Basic earnings per share | -1.4 USD/share | -2.02 USD/share | -6.23 USD/share | -3.1 USD/share | -1.9 USD/share |
| Diluted earnings per share | -1.4 USD/share | -2.31 USD/share | -6.23 USD/share | -3.1 USD/share | -1.9 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.